We are live on
!
Find out more
CS
Credit Suisse Portfolio holdings
AUM
$104B
1-Year Est. Return
34.76%
This Fund
S&P 500
This Quarter
Est. Return
-3.77%
1 Year Est. Return
+34.76%
3 Year Est. Return
+49.35%
5 Year Est. Return
+181.01%
10 Year Est. Return
+398.7%
AUM
$117B
AUM Growth
-$71.4B
(-38%)
Cap. Flow
-$63.6B
Cap. Flow
% of AUM
-54.42%
Top 10 Holdings %
Top 10 Hldgs %
19.61%
Holding
4,580
New
101
Increased
1,974
Reduced
1,229
Closed
1,024
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
S&P Global
SPGI
|
+$190M |
| 2 |
iShares China Large-Cap ETF
FXI
|
+$160M |
| 3 |
Microsoft
MSFT
|
+$150M |
| 4 |
State Street SPDR Dow Jones Industrial Average ETF Trust
DIA
|
+$136M |
| 5 |
Bank of America
BAC
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$306M |
| 2 |
Linde
LIN
|
+$290M |
| 3 |
Principal Financial Group
PFG
|
+$279M |
| 4 |
Evergy
EVRG
|
+$277M |
| 5 |
INFO
IHS Markit Ltd. Common Shares
INFO
|
+$240M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.91% |
| 2 | Healthcare | 15.27% |
| 3 | Financials | 13.61% |
| 4 | Consumer Discretionary | 10.3% |
| 5 | Industrials | 7.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SILK
2426
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $1.01M | ﹤0.01% |
24,534
+1,822
| +8% | +$64.1K |
|
2427
Arcus Biosciences
RCUS
$3.64B
| $1.01M | ﹤0.01% |
32,061
-1,723
| -5% | -$57.7K |
|
2428
OceanFirst Financial
OCFC
$1.91B
| $1.01M | ﹤0.01% |
50,201
-416
| -0.8% | -$9.27K |
|
|
TIGR
2429
UP Fintech Holding
TIGR
$861M
| $1.01M | ﹤0.01% |
206,163
-53,348
| -21% | -$239K |
|
2430
IonQ
IONQ
$16.6B
| $1.01M | ﹤0.01% |
79,035
+1,055
| +1% | +$14.2K |
|
|
DCH
2431
Dauch Corp
DCH
$1.51B
| $1.01M | ﹤0.01% |
129,644
+38,234
| +42% | +$326K |
|
2432
Standex International
SXI
$4.12B
| $1M | ﹤0.01% |
10,059
-157
| -2% | -$16.4K |
|
|
RAD
2433
DELISTED
Rite Aid Corporation
RAD
| $1M | ﹤0.01% |
114,643
-5,008
| -4% | -$52.4K |
|
|
UHT
2434
Universal Health Realty Income Trust
UHT
$594M
| $1M | ﹤0.01% |
17,170
-1,569
| -8% | -$90.9K |
|
2435
Prothena Corp
PRTA
$450M
| $1M | ﹤0.01% |
27,355
+3,783
| +16% | +$136K |
|
2436
Nu Holdings
NU
$66.9B
| $1M | ﹤0.01% |
+129,531
| New | +$1.04M |
|
|
VIVO
2437
DELISTED
Meridian Bioscience Inc
VIVO
| $998K | ﹤0.01% |
38,471
+4,314
| +13% | +$103K |
|
|
BRKL
2438
DELISTED
Brookline Bancorp
BRKL
| $996K | ﹤0.01% |
62,980
+914
| +1% | +$15.4K |
|
2439
Ginkgo Bioworks
DNA
$521M
| $994K | ﹤0.01% |
6,166
+2,743
| +80% | +$534K |
|
2440
PubMatic
PUBM
$810M
| $994K | ﹤0.01% |
+38,067
| New | +$975K |
|
|
GFGDU
2441
DELISTED
The Growth for Good Acquisition Corporation Unit
GFGDU
| $993K | ﹤0.01% |
100,000
-478,075
| -83% | -$4.77M |
|
2442
Apogee Enterprises
APOG
$908M
| $992K | ﹤0.01% |
20,899
-468
| -2% | -$21.8K |
|
2443
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$147M
| $992K | ﹤0.01% |
2,403
+954
| +66% | +$351K |
|
|
AQNU
2444
DELISTED
Algonquin Power & Utilities Corp Units
AQNU
| $991K | ﹤0.01% |
20,000
| – | – |
|
|
UGIC
2445
DELISTED
UGI Corporation
UGIC
| $990K | ﹤0.01% |
11,002
-284
| -3% | -$26.8K |
|
2446
La-Z-Boy
LZB
$1.69B
| $989K | ﹤0.01% |
37,499
+744
| +2% | +$23.8K |
|
2447
Kymera Therapeutics
KYMR
$8.94B
| $987K | ﹤0.01% |
23,305
+3,735
| +19% | +$158K |
|
2448
Relay Therapeutics
RLAY
$4.33B
| $987K | ﹤0.01% |
32,978
+2,760
| +9% | +$67K |
|
2449
Celldex Therapeutics
CLDX
$3.28B
| $986K | ﹤0.01% |
28,932
+827
| +3% | +$26.4K |
|
2450
American Vanguard Corp
AVD
$68.9M
| $979K | ﹤0.01% |
48,125
+5,621
| +13% | +$91.9K |
|
Similar funds
CSIA
CAN
VAM
CA
MNG
DPAM
ICG
CW
Credit Suisse's Q1 2022 Portfolio in Review
As of Q1 2022, Credit Suisse held 4,580 positions worth $117B, down 38% from $188B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Credit Suisse withdrew a net $63.6B in Q1 2022, closing 1,024 positions and reducing 1,229 holdings. Its most notable exit was IHS Markit Ltd. Common Shares, an estimated $240M position sold in full.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Credit Suisse opened a new position in AgileThought Inc worth $43.7M.
- Credit Suisse's largest Q1 2022 buy was AgileThought Inc: 9,605,775 shares worth $43.7M.
- Credit Suisse added most to S&P Global in Q1 2022, an estimated $190M increase.
- Credit Suisse's biggest Q1 2022 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $306M.
- Credit Suisse fully exited IHS Markit Ltd. Common Shares in Q1 2022, selling an estimated $240M.
- Credit Suisse's ten largest holdings make up 20% of its $117B portfolio in Q1 2022.
- Credit Suisse opened 101 new positions and closed 1,024 in Q1 2022.
- Credit Suisse's portfolio value fell 38% quarter-over-quarter to $117B.
Based on Credit Suisse's 13F filing for Q1 2022, filed 16 May 2022.